Christopher de Clinton Conway, Chief Philanthropy Officer and Executive Vice President for Strategic Communications at IBRI, shared on LinkedIn:
”Honored to support my boss, Alan Palkowitz, President and CEO of the Indiana Biosciences Research Institute (IBRI), as he testified before the U.S. Senate Committee on Finance Committee’s Subcommittee on Health Care on “Building a Resilient Health Care Future with Biotechnology.”
His testimony,
‘From Discovery to Delivery: A National Competitiveness Strategy for American Biotechnology,’
outlines a bold vision for strengthening U.S. leadership in biotechnology and ensuring innovations reach patients faster.
To read Dr. Palkowitz’s testimony, click here: From Discovery to Delivery: A National Competitiveness Strategy for American Biotechnology.”
You can also read: ‘Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring‘
